News Stories

Familial Hypercholesterolemia (FH) is among the most common genetic lipid disorders; left untreated, FH patients have a 20-fold increased risk for CHD.

Primary Issues Website - July 24, 2011

MIAMI, Fla. – (May 17, 2019) -- The National Lipid Association (NLA) today announced the release of an official scientific statement on Lipoprotein(a) [Lp(a)] clinical use at the NLA 2019 Scientific Sessions, May 16 – 19 at the Turnberry Isle Miami in Aventura, Florida.

Created by an international team of clinical lipid experts (see list on page 2), the statement is designed as a comprehensive source of guidance for medical professionals making decisions to improve the health and well-being of children and adults at risk of premature cardiovascular disease.

The National Lipid Association now has 100 lifetime members, which means $100,000 has been set aside for fellowship training programs in lipidology. The NLA is offering this program only through the end of 2013.

How does lifetime membership work? It’s simple: